| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel S. Goldberger | Insider | 2026-04-10 | 16,072 | $6.02 | $96.75kSell |
| Thomas J. Errico | Director | 2026-03-19 | 22,803 | $4.35 | $99.19kBuy |
| Thomas J. Errico | Director | 2026-03-19 | 19,252 | $6.43 | $123.79kBuy |
| Daniel S. Goldberger | Chief Executive Officer | 2026-01-26 | 20,375 | $7.47 | $152.20kBuy |
| Joshua S. Lev | Chief Financial Officer | 2025-12-04 | 2,500 | $5.05 | $12.63kSell |
| Daniel S. Goldberger | Chief Executive Officer | 2025-12-02 | 1,000 | $4.84 | $4.84kBuy |
| Joshua S. Lev | Chief Financial Officer | 2025-11-12 | 2,166 | $6.18 | $13.39kSell |
| Daniel S. Goldberger | Chief Executive Officer | 2025-08-11 | 1,000 | $4.23 | $4.23kBuy |
| Thomas J. Errico | Director | 2025-08-11 | 15,000 | $4.47 | $67.05kBuy |
| John P. Gandolfo | Director | 2025-05-23 | 1,800 | $5.01 | $9.02kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph P. Errico | 47.78% | 3,861,942 | $25.80M | Insider |
| Merck Global Health Innovation Fund LLC | 41.39% | 3,346,032 | $22.35M | Insider |
| James L. L. Tullis | 24.92% | 2,014,110 | $13.45M | Insider |
| Thomas J. Errico | 13.05% | 1,055,161 | $7.05M | Insider |
| Core Ventures II LLC | 8.00% | 646,342 | $4.32M | Insider |
| Peter S. Staats | 5.89% | 476,419 | $3.18M | Insider |
| Charles Steve Theofilos | 5.72% | 462,758 | $3.09M | Insider |
| Francis R. Amato | 4.56% | 368,355 | $2.46M | Insider |
| Daniel S. Goldberger | 3.61% | 291,471 | $1.95M | Insider |
| Vanguard Group Inc | 3.01% | 242,943 | $1.62M | Institution |